AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Gluwin M 2mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Ambrosia Pharmaceuticals

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Gluwin M 2mg/500mg Tablet SR

Diabex Duo 2mg/500mg Extended-Release Tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by managing blood glucose levels. Diabex Duo should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is vital, even with controlled glucose levels; abrupt cessation can elevate blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan, incorporating diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly influence diabetes control. Hypoglycemia (low blood sugar) is the most prevalent side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, juice) are crucial for prevention. Alcohol consumption increases hypoglycemia risk and should be minimized. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections; weight gain may occur. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart conditions should be disclosed to your doctor before commencing treatment. Consult your physician before use during pregnancy or breastfeeding. Regular blood glucose monitoring and periodic blood tests (including blood cell counts and liver function) are recommended.

Uses of Gluwin M 2mg/500mg Tablet SR

Managing type 2 diabetes

Major Benefits of Gluwin M 2mg/500mg Tablet SR:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the Gluwin M 2mg/500mg Tablet SR whole; avoid chewing, crushing, or breaking it. Consume this extended-release tablet with food.

Common Side effects of Gluwin M 2mg/500mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Gluwin M 2mg/500mg Tablet SR:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the Gluwin M 2mg/500mg Tablet SR whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.

How Gluwin M 2mg/500mg Tablet SR works:

Gluwin M SR tablets (2mg/500mg) combine glimepiride and metformin, two agents used to manage diabetes. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Gluwin M 2mg/500mg SR tablets is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Gluwin M 2mg/500mg tablet may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Gluwin M tablets (2mg/500mg) are contraindicated for breastfeeding mothers due to potential infant toxicity.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Gluwin M 2mg/500mg SR tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates Gluwin M 2mg/500mg SR tablet use. Physician consultation is necessary. Regular kidney function monitoring is recommended during treatment.

LiverLiverCAUTION

For individuals with liver impairment, Gluwin M 2mg/500mg sustained-release tablets require careful administration. Dosage modification of Gluwin M 2mg/500mg sustained-release tablets may be necessary. Physician consultation is advised. In patients exhibiting mild to moderate hepatic dysfunction, Gluwin M 2mg/500mg sustained-release tablets are typically initiated at a reduced dosage; however, their use is contraindicated in cases of severe liver disease.

What if you forget to take Gluwin M 2mg/500mg Tablet SR :

Should you forget a Gluwin M 2mg/500mg SR Tablet dose, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Gluwin M 2mg/500mg Tablet SR

LabelValue
Potential for Dependence None.
Type of Medication Medication for diabetes

FAQs on Gluwin M 2mg/500mg Tablet SR

Retain this medication within its original, sealed container or packaging. Store as directed on the packaging or label. Discard any leftover medication. Prevent access by children, pets, and others.
Gluwin M 2mg/500mg Tablet SR can cause lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this rare but potentially harmful side effect is more likely in individuals with kidney impairment, the elderly, or those who consume substantial alcohol. Symptoms may encompass muscle aches or weakness, vertigo, fatigue, cold extremities, respiratory distress, nausea, vomiting, abdominal pain, and bradycardia. Should these symptoms appear, discontinue Gluwin M 2mg/500mg Tablet SR and seek immediate medical attention.
Gluwin M 2mg/500mg sustained-release tablets contain glimepiride and metformin, two medications used together to manage type 2 diabetes mellitus in adults. This treatment improves blood sugar control when combined with a healthy diet and regular physical activity. Glimepiride stimulates insulin secretion from the pancreas to reduce blood glucose, while metformin decreases hepatic glucose production and enhances insulin responsiveness. This dual medication is unsuitable for treating type 1 diabetes.
Gluwin M 2mg/500mg Tablets SR may cause common side effects including low blood sugar (hypoglycemia), taste changes, nausea, abdominal pain, diarrhea, and headache. Rare but potentially serious adverse reactions such as lactic acidosis may occur. Prolonged treatment may result in vitamin B12 deficiency.
Prolonged use of Gluwin M 2mg/500mg SR tablets can indeed lead to Vitamin B12 deficiency. This medication hinders the stomach's absorption of Vitamin B12. Untreated deficiency may result in anemia, neurological complications such as tingling and numbness in the extremities, muscle weakness, urinary dysfunction, cognitive changes, and impaired coordination. To mitigate these risks, supplemental Vitamin B12 intake, at least annually, has been proposed by some studies.
Indeed, Gluwin M 2mg/500mg Sustained-Release Tablets can induce hypoglycemia. Low blood sugar manifests as nausea, headache, irritability, hunger pangs, sweating, lightheadedness, tachycardia, and feelings of anxiety or tremor. The risk increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Consequently, consistent blood glucose monitoring is crucial. Carrying readily available simple sugars, such as glucose tablets, honey, or fruit juice, is recommended.
Combining Gluwin M 2mg/500mg SR tablets and alcohol is unsafe. This combination can reduce blood glucose, potentially causing hypoglycemia, and raises the risk of lactic acidosis.
Gluwin M 2mg/500mg Tablet...
48
MRP 58
17% off